Annual Accounts Payable
$3.13 M
+$515.00 K+19.69%
December 31, 2023
Summary
- As of February 7, 2025, LYRA annual accounts payable is $3.13 million, with the most recent change of +$515.00 thousand (+19.69%) on December 31, 2023.
- During the last 3 years, LYRA annual accounts payable has risen by +$2.21 million (+239.59%).
- LYRA annual accounts payable is now at all-time high.
Performance
LYRA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.29 M
-$2.68 M-53.89%
September 30, 2024
Summary
- As of February 7, 2025, LYRA quarterly accounts payable is $2.29 million, with the most recent change of -$2.68 million (-53.89%) on September 30, 2024.
- Over the past year, LYRA quarterly accounts payable has dropped by -$2.76 million (-54.65%).
- LYRA quarterly accounts payable is now -54.65% below its all-time high of $5.05 million, reached on September 30, 2023.
Performance
LYRA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LYRA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.7% | -54.6% |
| 3 y3 years | +239.6% | -54.6% |
| 5 y5 years | +396.2% | -54.6% |
LYRA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.7% | -54.6% | +37.3% |
| 5 y | 5-year | at high | +239.6% | -54.6% | +332.4% |
| alltime | all time | at high | +396.2% | -54.6% | +332.4% |
Lyra Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.29 M(-53.9%) |
| Jun 2024 | - | $4.97 M(+74.8%) |
| Mar 2024 | - | $2.84 M(-9.2%) |
| Dec 2023 | $3.13 M(+19.7%) | $3.13 M(-38.0%) |
| Sep 2023 | - | $5.05 M(+20.7%) |
| Jun 2023 | - | $4.19 M(+6.0%) |
| Mar 2023 | - | $3.95 M(+51.0%) |
| Dec 2022 | $2.62 M | $2.62 M(-9.8%) |
| Sep 2022 | - | $2.90 M(+73.7%) |
| Jun 2022 | - | $1.67 M(-30.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.41 M(-22.9%) |
| Dec 2021 | $3.13 M(+238.9%) | $3.13 M(+7.3%) |
| Sep 2021 | - | $2.91 M(+53.3%) |
| Jun 2021 | - | $1.90 M(+62.4%) |
| Mar 2021 | - | $1.17 M(+26.8%) |
| Dec 2020 | $922.00 K(-13.8%) | $922.00 K(+74.0%) |
| Sep 2020 | - | $530.00 K(-53.8%) |
| Jun 2020 | - | $1.15 M(-15.6%) |
| Mar 2020 | - | $1.36 M(+27.0%) |
| Dec 2019 | $1.07 M(+69.4%) | $1.07 M |
| Dec 2018 | $631.00 K | - |
FAQ
- What is Lyra Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Lyra Therapeutics?
- What is Lyra Therapeutics annual accounts payable year-on-year change?
- What is Lyra Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly accounts payable year-on-year change?
What is Lyra Therapeutics annual accounts payable?
The current annual accounts payable of LYRA is $3.13 M
What is the all time high annual accounts payable for Lyra Therapeutics?
Lyra Therapeutics all-time high annual accounts payable is $3.13 M
What is Lyra Therapeutics annual accounts payable year-on-year change?
Over the past year, LYRA annual accounts payable has changed by +$515.00 K (+19.69%)
What is Lyra Therapeutics quarterly accounts payable?
The current quarterly accounts payable of LYRA is $2.29 M
What is the all time high quarterly accounts payable for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly accounts payable is $5.05 M
What is Lyra Therapeutics quarterly accounts payable year-on-year change?
Over the past year, LYRA quarterly accounts payable has changed by -$2.76 M (-54.65%)